SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001437749-16-034334
Filing Date
2016-06-24
Accepted
2016-06-23 20:30:17
Documents
2
Group Members
BRIGITTE SMITHGBS BIOVENTURES III

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A gbsvpl20160623_sc13da.htm SC 13D/A 82599
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 7814
  Complete submission text file 0001437749-16-034334.txt   92061
Mailing Address 150 COMMERCIAL STREET SUNNYVALE CA 94086
Business Address 150 COMMERCIAL STREET SUNNYVALE CA 94086 4085301900
VIVEVE MEDICAL, INC. (Subject) CIK: 0000879682 (see all company filings)

IRS No.: 043153858 | State of Incorp.: B0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42378 | Film No.: 161729676
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000
Business Address LEVEL 5 71 COLLINS ST MELBOURNE C3 VIC 3000 61386509921
GBS Venture Partners Pty, Ltd (Filed by) CIK: 0001542845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: SC 13D/A